Industry: Medical Devices & Consumables
Published Date: 2024-12-07
Pages: 102 Pages
Report ld: 3398160
Request Sample
Customized Report
Fully Automated Blood Culture System Market Size(US$)

CAGR 2024-2030
4.9%
Market Size,2030
USD 2,182
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Fully Automated Blood Culture System was estimated to be worth US$ 1561 million in 2023 and is forecast to a readjusted size of US$ 2182 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030.
The fully automated blood culture system is a system used to quickly and accurately detect the presence of microorganisms (such as bacteria, fungi, etc.) in a patient's blood. This type of system is widely used in medical settings such as hospitals and clinical laboratories, especially in the diagnosis of bloodstream infections (such as sepsis), and plays an extremely important role. The fully automated blood culture system not only improves the efficiency and accuracy of blood culture, but also significantly shortens the diagnosis time, provides timely information on pathogenic bacteria to doctors, and helps develop precise treatment plans.
North American market for Fully Automated Blood Culture System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fully Automated Blood Culture System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Fully Automated Blood Culture System was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Fully Automated Blood Culture System include Thermo Fisher Scientific, Biomérieux, BD, Biolab Scientific, Bruker, Meihua, Scenker, Auto Bio, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Fully Automated Blood Culture System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fully Automated Blood Culture System by region & country, by Type, and by Application.
The Fully Automated Blood Culture System market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully Automated Blood Culture System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fully Automated Blood Culture System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fully Automated Blood Culture System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fully Automated Blood Culture System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fully Automated Blood Culture System Product Introduction
1.2 Global Fully Automated Blood Culture System Market Size Forecast
1.2.1 Global Fully Automated Blood Culture System Sales Value (2019-2030)
1.2.2 Global Fully Automated Blood Culture System Sales Volume (2019-2030)
1.2.3 Global Fully Automated Blood Culture System Sales Price (2019-2030)
1.3 Fully Automated Blood Culture System Market Trends & Drivers
1.3.1 Fully Automated Blood Culture System Industry Trends
1.3.2 Fully Automated Blood Culture System Market Drivers & Opportunity
1.3.3 Fully Automated Blood Culture System Market Challenges
1.3.4 Fully Automated Blood Culture System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fully Automated Blood Culture System Players Revenue Ranking (2023)
2.2 Global Fully Automated Blood Culture System Revenue by Company (2019-2024)
2.3 Global Fully Automated Blood Culture System Players Sales Volume Ranking (2023)
2.4 Global Fully Automated Blood Culture System Sales Volume by Company Players (2019-2024)
2.5 Global Fully Automated Blood Culture System Average Price by Company (2019-2024)
2.6 Key Manufacturers Fully Automated Blood Culture System Manufacturing Base and Headquarters
2.7 Key Manufacturers Fully Automated Blood Culture System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fully Automated Blood Culture System
2.9 Fully Automated Blood Culture System Market Competitive Analysis
2.9.1 Fully Automated Blood Culture System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Fully Automated Blood Culture System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully Automated Blood Culture System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Aerobic Culture System
3.1.2 Anaerobic Culture System
3.2 Global Fully Automated Blood Culture System Sales Value by Type
3.2.1 Global Fully Automated Blood Culture System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fully Automated Blood Culture System Sales Value, by Type (2019-2030)
3.2.3 Global Fully Automated Blood Culture System Sales Value, by Type (%) (2019-2030)
3.3 Global Fully Automated Blood Culture System Sales Volume by Type
3.3.1 Global Fully Automated Blood Culture System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Fully Automated Blood Culture System Sales Volume, by Type (2019-2030)
3.3.3 Global Fully Automated Blood Culture System Sales Volume, by Type (%) (2019-2030)
3.4 Global Fully Automated Blood Culture System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratory
4.1.3 Others
4.2 Global Fully Automated Blood Culture System Sales Value by Application
4.2.1 Global Fully Automated Blood Culture System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fully Automated Blood Culture System Sales Value, by Application (2019-2030)
4.2.3 Global Fully Automated Blood Culture System Sales Value, by Application (%) (2019-2030)
4.3 Global Fully Automated Blood Culture System Sales Volume by Application
4.3.1 Global Fully Automated Blood Culture System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Fully Automated Blood Culture System Sales Volume, by Application (2019-2030)
4.3.3 Global Fully Automated Blood Culture System Sales Volume, by Application (%) (2019-2030)
4.4 Global Fully Automated Blood Culture System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Fully Automated Blood Culture System Sales Value by Region
5.1.1 Global Fully Automated Blood Culture System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fully Automated Blood Culture System Sales Value by Region (2019-2024)
5.1.3 Global Fully Automated Blood Culture System Sales Value by Region (2025-2030)
5.1.4 Global Fully Automated Blood Culture System Sales Value by Region (%), (2019-2030)
5.2 Global Fully Automated Blood Culture System Sales Volume by Region
5.2.1 Global Fully Automated Blood Culture System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Fully Automated Blood Culture System Sales Volume by Region (2019-2024)
5.2.3 Global Fully Automated Blood Culture System Sales Volume by Region (2025-2030)
5.2.4 Global Fully Automated Blood Culture System Sales Volume by Region (%), (2019-2030)
5.3 Global Fully Automated Blood Culture System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Fully Automated Blood Culture System Sales Value, 2019-2030
5.4.2 North America Fully Automated Blood Culture System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Fully Automated Blood Culture System Sales Value, 2019-2030
5.5.2 Europe Fully Automated Blood Culture System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Fully Automated Blood Culture System Sales Value, 2019-2030
5.6.2 Asia Pacific Fully Automated Blood Culture System Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Fully Automated Blood Culture System Sales Value, 2019-2030
5.7.2 South America Fully Automated Blood Culture System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fully Automated Blood Culture System Sales Value, 2019-2030
5.8.2 Middle East & Africa Fully Automated Blood Culture System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fully Automated Blood Culture System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fully Automated Blood Culture System Sales Value
6.2.1 Key Countries/Regions Fully Automated Blood Culture System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Fully Automated Blood Culture System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Fully Automated Blood Culture System Sales Value, 2019-2030
6.3.2 United States Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fully Automated Blood Culture System Sales Value, 2019-2030
6.4.2 Europe Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fully Automated Blood Culture System Sales Value, 2019-2030
6.5.2 China Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fully Automated Blood Culture System Sales Value, 2019-2030
6.6.2 Japan Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fully Automated Blood Culture System Sales Value, 2019-2030
6.7.2 South Korea Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fully Automated Blood Culture System Sales Value, 2019-2030
6.8.2 Southeast Asia Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fully Automated Blood Culture System Sales Value, 2019-2030
6.9.2 India Fully Automated Blood Culture System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fully Automated Blood Culture System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Information
7.1.2 Thermo Fisher Scientific Introduction and Business Overview
7.1.3 Thermo Fisher Scientific Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Scientific Fully Automated Blood Culture System Product Offerings
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Biomérieux
7.2.1 Biomérieux Company Information
7.2.2 Biomérieux Introduction and Business Overview
7.2.3 Biomérieux Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Biomérieux Fully Automated Blood Culture System Product Offerings
7.2.5 Biomérieux Recent Development
7.3 BD
7.3.1 BD Company Information
7.3.2 BD Introduction and Business Overview
7.3.3 BD Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 BD Fully Automated Blood Culture System Product Offerings
7.3.5 BD Recent Development
7.4 Biolab Scientific
7.4.1 Biolab Scientific Company Information
7.4.2 Biolab Scientific Introduction and Business Overview
7.4.3 Biolab Scientific Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Biolab Scientific Fully Automated Blood Culture System Product Offerings
7.4.5 Biolab Scientific Recent Development
7.5 Bruker
7.5.1 Bruker Company Information
7.5.2 Bruker Introduction and Business Overview
7.5.3 Bruker Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Bruker Fully Automated Blood Culture System Product Offerings
7.5.5 Bruker Recent Development
7.6 Meihua
7.6.1 Meihua Company Information
7.6.2 Meihua Introduction and Business Overview
7.6.3 Meihua Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Meihua Fully Automated Blood Culture System Product Offerings
7.6.5 Meihua Recent Development
7.7 Scenker
7.7.1 Scenker Company Information
7.7.2 Scenker Introduction and Business Overview
7.7.3 Scenker Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Scenker Fully Automated Blood Culture System Product Offerings
7.7.5 Scenker Recent Development
7.8 Auto Bio
7.8.1 Auto Bio Company Information
7.8.2 Auto Bio Introduction and Business Overview
7.8.3 Auto Bio Fully Automated Blood Culture System Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Auto Bio Fully Automated Blood Culture System Product Offerings
7.8.5 Auto Bio Recent Development
8 Industry Chain Analysis
8.1 Fully Automated Blood Culture System Industrial Chain
8.2 Fully Automated Blood Culture System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fully Automated Blood Culture System Sales Model
8.5.2 Sales Channel
8.5.3 Fully Automated Blood Culture System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fully Automated Blood Culture System market is projected to grow from US$ 1710 million in 2025 to US$ 2379 million by 2032, at a CAGR of 4.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 139
USD 4900.00
(Single User License)
The global Fully Automated Blood Culture System market size was US$ 1710 million in 2025 and is forecast to reach a readjusted size of US$ 2379 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 77
USD 4250.00
(Single User License)
The global Fully Automated Blood Culture System market was valued at US$ 1710 million in 2025 and is anticipated to reach US$ 2379 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 113
USD 2900.00
(Single User License)
The global market for Fully Automated Blood Culture System was estimated to be worth US$ 1710 million in 2025 and is projected to reach US$ 2379 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 106
USD 3950.00
(Single User License)
The global Fully Automated Blood Culture System market size was US$ 1637 million in 2024 and is forecast to a readjusted size of US$ 2278 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
The global Fully Automated Blood Culture System market is projected to grow from US$ 1637 million in 2024 to US$ 2278 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 140
USD 4900.00
(Single User License)
The global market for Fully Automated Blood Culture System was estimated to be worth US$ 1637 million in 2024 and is forecast to a readjusted size of US$ 2278 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 106
USD 3950.00
(Single User License)
The global market for Fully Automated Blood Culture System was valued at US$ 1637 million in the year 2024 and is projected to reach a revised size of US$ 2278 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published Date: 2025-03-10
Pages: 84
USD 2900.00
(Single User License)
The global Fully Automated Blood Culture System revenue was US$ 1561 million in 2023 and is forecast to a readjusted size of US$ 2182 million by 2030 with a CAGR of 4.9% during the review period (2024-2030).
Published Date: 2024-12-07
Pages: 103
USD 4350.00
(Single User License)
Valued at US$ 1637 million in 2024, the global Fully Automated Blood Culture System market is forecast to reach US$ 2182 million by 2030, at a CAGR of 4.9% during the forecast period.
Published Date: 2024-12-07
Pages: 128
USD 4900.00
(Single User License)
The global Fully Automated Blood Culture System market is projected to grow from US$ 1710 million in 2025 to US$ 2379 million by 2032, at a CAGR of 4.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 139
The global Fully Automated Blood Culture System market size was US$ 1710 million in 2025 and is forecast to reach a readjusted size of US$ 2379 million by 2032 with a CAGR of 4.9% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 77
The global Fully Automated Blood Culture System market was valued at US$ 1710 million in 2025 and is anticipated to reach US$ 2379 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-01-08
Pages: 113
The global market for Fully Automated Blood Culture System was estimated to be worth US$ 1710 million in 2025 and is projected to reach US$ 2379 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-01-08
Pages: 106
The global Fully Automated Blood Culture System market size was US$ 1637 million in 2024 and is forecast to a readjusted size of US$ 2278 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
The global Fully Automated Blood Culture System market is projected to grow from US$ 1637 million in 2024 to US$ 2278 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 140
The global market for Fully Automated Blood Culture System was estimated to be worth US$ 1637 million in 2024 and is forecast to a readjusted size of US$ 2278 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 106
The global market for Fully Automated Blood Culture System was valued at US$ 1637 million in the year 2024 and is projected to reach a revised size of US$ 2278 million by 2031, growing at a CAGR of 4.9% during the forecast period.
Published: 2025-03-10
Pages: 84
The global Fully Automated Blood Culture System revenue was US$ 1561 million in 2023 and is forecast to a readjusted size of US$ 2182 million by 2030 with a CAGR of 4.9% during the review period (2024-2030).
Published: 2024-12-07
Pages: 103
Valued at US$ 1637 million in 2024, the global Fully Automated Blood Culture System market is forecast to reach US$ 2182 million by 2030, at a CAGR of 4.9% during the forecast period.
Published: 2024-12-07
Pages: 128
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now